VANGUARD ASSET MANAGEMENT, Ltd
Position in GH — Guardant Health, Inc.
CIK 1680208
London, EC4N 8AF, X0
Position in GH
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$17,500,249
+$8,009,601 QoQ
Shares Held
116,645
+13.5% QoQ
Ownership
0.087%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#125
of 593 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GH Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026VANGUARD ASSET MANAGEMENT, Ltd holds $1,282,205,392 across 31 Diagnostics & Research names. GH ranks #13 (1.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
729,800 | $365,892,528 | |
| 2 | DHR |
Danaher Corp /De/
|
1,222,312 | $232,825,989 | |
| 3 | IDXX |
Idexx Laboratories Inc /De
|
155,306 | $81,759,290 | |
| 4 | A |
Agilent Technologies, Inc.
|
548,583 | $72,868,279 | |
| 5 | NTRA |
Natera, Inc.
|
262,485 | $71,251,553 | |
| 6 | WAT |
Waters Corp /De/
|
189,305 | $70,996,947 | |
| 7 | IQV |
Iqvia Holdings Inc.
|
333,682 | $64,474,036 | |
| 8 | MTD |
Mettler Toledo International Inc/
|
42,093 | $53,774,228 |
All Filings in GH
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $17,500,249 | 116,645 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $9,490,648 | 102,746 | Shares | Defined | 2026-05-08 | |
| No filing history on record for this holder in this stock. | ||||||